BFM
PTHS

Boothbay Fund Management’s Pelthos Therapeutics PTHS Stock Holding History

Boothbay Fund Management’s Portfolio PTHS Stock Details PTHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88M Buy
101,976
+20,118
+25% +$516K 0.04% 562
2026
Q1 		$1.72M Buy
81,858
+1,178
+1% +$27.9K 0.02% 690
2025
Q4 		$2.5M Buy
80,680
+59,435
+280% +$1.71M 0.04% 495
2025
Q3 		$595K Buy
+21,245
New +$516K 0.01% 1060
2025
Q2 		– Sell
-13,075
Closed -$186K – 1820
2025
Q1 		$186K Buy
+13,075
New +$224K ﹤0.01% 1177

Other funds holding PTHS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Boothbay Fund Management's PTHS Position: Q2 2026 in Review

Boothbay Fund Management increased its Pelthos Therapeutics (PTHS) stake by 25% in Q2 2026, buying an estimated $516K and bringing the position to 101,976 shares worth $2.88M. The position accounts for 0.04% of the portfolio, ranked #562.

Boothbay Fund Management first reported a position in PTHS in Q1 2025 and has held it in 5 quarters since. 24 funds tracked by Wall St. Rank hold PTHS as of Q2 2026.

  • Boothbay Fund Management held 101,976 shares of Pelthos Therapeutics worth $2.88M as of Q2 2026.
  • Boothbay Fund Management bought 20,118 Pelthos Therapeutics shares in Q2 2026, an estimated $516K.
  • Pelthos Therapeutics made up 0.04% of Boothbay Fund Management's portfolio in Q2 2026, its #562 holding.
  • Boothbay Fund Management first reported a position in Pelthos Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 24 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.